Results 111 to 120 of about 308,984 (157)
Some of the next articles are maybe not open access.
Medical Clinics of North America, 2013
The diabetic Charcot foot is rare, but a life-changing event affecting quality of life, and it risks amputation of the limb. There is no high quality evidence base governing treatment, causing clinicians to rely on low-quality, underpowered studies and expert opinion.
Robert Frykberg, Lee C Rogers
exaly +6 more sources
The diabetic Charcot foot is rare, but a life-changing event affecting quality of life, and it risks amputation of the limb. There is no high quality evidence base governing treatment, causing clinicians to rely on low-quality, underpowered studies and expert opinion.
Robert Frykberg, Lee C Rogers
exaly +6 more sources
Diabetic Medicine, 2000
Abstract Aims To review the clinical manifestations of the Charcot foot in diabetes mellitus, with particular reference to theories concerning aetiology. Methods Systematic review of the published literature, searching for the keywords ‘Charcot’, ‘foot and diabetes’ and ‘neuropathy’ on Medline, as well as by examination of the references in recent ...
W, Jeffcoate, J, Lima, L, Nobrega
exaly +3 more sources
Abstract Aims To review the clinical manifestations of the Charcot foot in diabetes mellitus, with particular reference to theories concerning aetiology. Methods Systematic review of the published literature, searching for the keywords ‘Charcot’, ‘foot and diabetes’ and ‘neuropathy’ on Medline, as well as by examination of the references in recent ...
W, Jeffcoate, J, Lima, L, Nobrega
exaly +3 more sources
Bone and Joint Journal, 2016
Neuropathic changes in the foot are common with a prevalence of approximately 1%. The diagnosis of neuropathic arthropathy is often delayed in diabetic patients with harmful consequences including amputation. The appropriate diagnosis and treatment can avoid an extensive programme of treatment with significant morbidity for the patient, high costs and
K Trieb
exaly +3 more sources
Neuropathic changes in the foot are common with a prevalence of approximately 1%. The diagnosis of neuropathic arthropathy is often delayed in diabetic patients with harmful consequences including amputation. The appropriate diagnosis and treatment can avoid an extensive programme of treatment with significant morbidity for the patient, high costs and
K Trieb
exaly +3 more sources
Clinics in Podiatric Medicine and Surgery, 2022
The Charcot diabetic foot presents unique challenges to the podiatric surgeon in the quest to salvage the limb. This disorder is an intersection of prototypical metabolic diseases and neurodegenerative disorder. Furthermore, it can be considered a disease of bone and ligaments that is often complicated by peripheral vascular disease and serious deep ...
William, Grant, Lisa, Grant-McDonald
openaire +2 more sources
The Charcot diabetic foot presents unique challenges to the podiatric surgeon in the quest to salvage the limb. This disorder is an intersection of prototypical metabolic diseases and neurodegenerative disorder. Furthermore, it can be considered a disease of bone and ligaments that is often complicated by peripheral vascular disease and serious deep ...
William, Grant, Lisa, Grant-McDonald
openaire +2 more sources
Journal of the American Podiatric Medical Association, 1989
Successful management of the Charcot foot is one of the most challenging undertakings faced by physicians. However, many times such patients undergo prolonged and attentive care only to develop further deformity, and in many cases succumb to amputation.
A S, Banks, E D, McGlamry
openaire +2 more sources
Successful management of the Charcot foot is one of the most challenging undertakings faced by physicians. However, many times such patients undergo prolonged and attentive care only to develop further deformity, and in many cases succumb to amputation.
A S, Banks, E D, McGlamry
openaire +2 more sources
The Lancet, 2002
The Charcot foot Neuroarthropathy, or Charcot foot, was first described by Jean-Martin Charcot in 1883 in patients with tabes dorsalis, but nowadays it is reported most frequently as a complication of diabetes. Two-thirds of people with Charcot foot have type 2 diabetes. Men and women are equally affected. The disorder affects about 0.2% of people with
Agnès, Hartemann-Heurtier +2 more
openaire +2 more sources
The Charcot foot Neuroarthropathy, or Charcot foot, was first described by Jean-Martin Charcot in 1883 in patients with tabes dorsalis, but nowadays it is reported most frequently as a complication of diabetes. Two-thirds of people with Charcot foot have type 2 diabetes. Men and women are equally affected. The disorder affects about 0.2% of people with
Agnès, Hartemann-Heurtier +2 more
openaire +2 more sources
Orthopaedic Nursing, 2001
Charcot joint is the painless, degenerative, progressive neuropathic destruction of the bony architecture of one or more joints of the feet. Diabetes mellitus is the most common cause of Charcot joint in North America, although the exact etiology is uncertain. The classic presenting complaint involves unilateral painless swelling of the lower extremity
D S, Houston, J, Curran
openaire +2 more sources
Charcot joint is the painless, degenerative, progressive neuropathic destruction of the bony architecture of one or more joints of the feet. Diabetes mellitus is the most common cause of Charcot joint in North America, although the exact etiology is uncertain. The classic presenting complaint involves unilateral painless swelling of the lower extremity
D S, Houston, J, Curran
openaire +2 more sources
Der Orthopäde, 1999
Charcot foot in its original sense is equivalent to stage 4 of hereditary motor and sensory neuropathy (HMSN) which is known as Charcot-Marie-Tooth disease since 1886. This entity, which can be subdivided into 3 groups including subgroups, predominantly begins during childhood and progresses slowly. The first symptom, often unnoticed by the patient for
H, Zwipp +3 more
openaire +2 more sources
Charcot foot in its original sense is equivalent to stage 4 of hereditary motor and sensory neuropathy (HMSN) which is known as Charcot-Marie-Tooth disease since 1886. This entity, which can be subdivided into 3 groups including subgroups, predominantly begins during childhood and progresses slowly. The first symptom, often unnoticed by the patient for
H, Zwipp +3 more
openaire +2 more sources
British Journal of Hospital Medicine, 2008
A 55-year-old man with insulindependent diabetes mellitus was referred by his GP with a 3-month history of a red, warm, swollen foot that can clinically mimicked cellulitis and had failed to respond to oral antibiotics. Plain radiographs (Figure 1) and magnetic resonance imaging (Figure 2) showed a dislocation of the tarsometatarsal joint with diffuse ...
Rupen, Dattani +2 more
openaire +2 more sources
A 55-year-old man with insulindependent diabetes mellitus was referred by his GP with a 3-month history of a red, warm, swollen foot that can clinically mimicked cellulitis and had failed to respond to oral antibiotics. Plain radiographs (Figure 1) and magnetic resonance imaging (Figure 2) showed a dislocation of the tarsometatarsal joint with diffuse ...
Rupen, Dattani +2 more
openaire +2 more sources
Current Diabetes Reviews, 2012
Charcot neuroarthropathy (CN) is a devastating condition affecting the feet in patients with diabetes. The pathophysiology of (CN) is still incompletely understood, although main etiological components have been identified. The cornerstone of treatment of acute CN is immediate effective offloading, typically with total contact casting, and reduction in
Dissanayake, Sanjay U. +2 more
openaire +4 more sources
Charcot neuroarthropathy (CN) is a devastating condition affecting the feet in patients with diabetes. The pathophysiology of (CN) is still incompletely understood, although main etiological components have been identified. The cornerstone of treatment of acute CN is immediate effective offloading, typically with total contact casting, and reduction in
Dissanayake, Sanjay U. +2 more
openaire +4 more sources